Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-071926
Filing Date
2006-12-26
Accepted
2006-12-26 19:54:06
Documents
1
Period of Report
2006-12-19

Document Format Files

Seq Description Document Type Size
1 FENTON FORM 4 FOR OPTION GRANT rrd140600.html 4  
1 FENTON FORM 4 FOR OPTION GRANT rrd140600.xml 4 3818
  Complete submission text file 0001181431-06-071926.txt   5514
Mailing Address
Business Address 1003 WEST SEVENTH ST SUITE 401 FREDERICK MD 21701 3016968889
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 203-624-7000
Fenton Mary Kay (Reporting) CIK: 0001378589 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 061299551